Catalyst Wire Dossier Catalyst Wire Dossier

SABRIL

VIGABATRIN · Lundbeck Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

45 regulatory and trial events tracked for SABRIL, covering 2008-03-04 to 2026-03-18. Get the full timeline:

Most recent: FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)

See pricing